Medication Collaboration Feasibility Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorNorthwestern University

About this trial

This study examines the feasibility and acceptability of a brief medication collaboration intervention among older adults (age 60+) with early-stage dementia or mild cognitive impairment who take multiple medications and their family caregivers. The main aims are to: 1) determine the feasibility and acceptability of the intervention for older adults with early-stage dementia and their family caregivers, and 2) explore the effects of intervention on medication collaboration, medication adherence, and beliefs about dementia and autonomy.

In this study, participants will: 1) complete a 15-30-minute baseline interview (by Zoom or phone), 2) participate together in a 45-60-minute virtual intervention led by an interventionist that includes:

Assessment of medication responsibilities and beliefs. Education about dementia and medication management. Cognitive restructuring to address beliefs about independence and caregiver assistance.

Collaborative planning for medication responsibilities and routines; and lastly 3) complete a 15-20-minute one-month follow-up interview (by Zoom or phone) to assess the intervention's acceptability and changes in medication management outcomes.

Eligibility criteria

Qualifiers

Age 60 or older

Diagnosis of dementia, Alzhimer's Disease or Mild Cognitive Impairment

Quick Dementia Rating Scale Score 2-12 (inclusive of mild cognitive impairment and mild dementia)

Taking 3 or more medications

Disqualifiers

adults unable to consent

Trial design

Treatments tested in this trial

  • Medication Collaboration Intervention

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators